Moore Capital Management LP purchased a new stake in Oracle Corporation (NYSE:ORCL – Free Report) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 25,900 shares of the enterprise software provider’s stock, valued at approximately $3,796,000.
Other large investors have also added to or reduced their stakes in the company. Brighton Jones LLC lifted its holdings in shares of Oracle by 189.3% during the 4th quarter. Brighton Jones LLC now owns 153,580 shares of the enterprise software provider’s stock worth $25,593,000 after acquiring an additional 100,494 shares during the period. Revolve Wealth Partners LLC increased its stake in Oracle by 8.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 5,418 shares of the enterprise software provider’s stock valued at $903,000 after acquiring an additional 404 shares during the last quarter. Sivia Capital Partners LLC raised its position in Oracle by 21.5% during the second quarter. Sivia Capital Partners LLC now owns 4,348 shares of the enterprise software provider’s stock valued at $951,000 after purchasing an additional 768 shares in the last quarter. United Bank raised its position in Oracle by 6.8% during the second quarter. United Bank now owns 15,038 shares of the enterprise software provider’s stock valued at $3,288,000 after purchasing an additional 963 shares in the last quarter. Finally, Schnieders Capital Management LLC. lifted its stake in Oracle by 19.2% during the second quarter. Schnieders Capital Management LLC. now owns 52,856 shares of the enterprise software provider’s stock worth $11,556,000 after purchasing an additional 8,530 shares during the last quarter. Institutional investors and hedge funds own 42.44% of the company’s stock.
Insiders Place Their Bets
In other Oracle news, Vice Chairman Jeffrey Henley sold 400,000 shares of the stock in a transaction that occurred on Wednesday, June 24th. The shares were sold at an average price of $159.16, for a total transaction of $63,664,000.00. Following the completion of the sale, the insider owned 400,000 shares of the company’s stock, valued at approximately $63,664,000. This represents a 50.00% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 40.90% of the company’s stock.
Oracle Stock Performance
Oracle (NYSE:ORCL – Get Free Report) last released its quarterly earnings results on Wednesday, June 10th. The enterprise software provider reported $2.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.96 by $0.15. Oracle had a net margin of 25.37% and a return on equity of 58.62%. The firm had revenue of $19.18 billion during the quarter, compared to the consensus estimate of $19.10 billion. During the same quarter last year, the firm earned $1.70 earnings per share. The company’s revenue for the quarter was up 20.6% on a year-over-year basis. Oracle has set its Q1 2027 guidance at 1.720-1.760 EPS and its FY 2027 guidance at 8.050-8.050 EPS. On average, equities research analysts predict that Oracle Corporation will post 6.49 earnings per share for the current year.
Oracle Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, July 24th. Investors of record on Friday, July 10th were issued a $0.50 dividend. The ex-dividend date was Friday, July 10th. This represents a $2.00 annualized dividend and a yield of 1.3%. Oracle’s dividend payout ratio is presently 34.31%.
Oracle News Roundup
Here are the key news stories impacting Oracle this week:
- Positive Sentiment: Oracle’s AI opportunity remains a major potential catalyst. One analysis highlights the company’s large AI-related bookings and its position as a beneficiary of Nvidia’s expanding technology ecosystem, while another reports that Erste Group Bank raised its FY2028 EPS estimates. Nvidia Changes Everything, Says Top Investor About Oracle Stock FY2028 EPS Estimates for Oracle Boosted by Erste Group Bank
- Positive Sentiment: Oracle Health is expanding its Clinical AI Agent in the United States to support professional-fee coding, real-time dictation and chart review. Integrating these tools with Oracle’s cloud and AI stack could strengthen its role in mission-critical healthcare systems and support longer-term cloud growth. Is Oracle Using Healthcare AI to Quietly Redefine Its Core Cloud Strategy?
- Neutral Sentiment: Oracle was identified as a key vendor in blockchain and 5G-edge technology, and was included among suppliers expected to benefit from growth in the inventory-control software market. These reports point to addressable-market opportunities but do not provide a new financial forecast or contract announcement. Oracle Is Named a Key Vendor in Blockchain and 5G Edge
- Negative Sentiment: Investors remain concerned that Oracle’s spending to build AI capacity will arrive before the associated revenue. Record bookings may take time to convert into sales, potentially pressuring cash flow, margins and near-term earnings. The Bill for Oracle’s AI Build Arrived Before the Revenue
- Negative Sentiment: Commentary describing Oracle as a potential chronic underperformer, along with comparisons showing weakness versus the broader market, added to the cautious tone. The company’s upcoming earnings report is therefore viewed as an important catalyst capable of producing a sizable move. Oracle May Remain a Chronic Underperformer Oracle at a Crossroads: Big Earnings Could Trigger a Massive Swing
Wall Street Analyst Weigh In
A number of equities analysts have recently commented on the company. Barclays boosted their price target on Oracle from $240.00 to $250.00 and gave the stock an “overweight” rating in a report on Thursday, June 11th. Bank of America boosted their target price on Oracle from $200.00 to $240.00 and gave the stock a “buy” rating in a research note on Tuesday, June 9th. Wolfe Research restated an “outperform” rating and issued a $225.00 price target on shares of Oracle in a research note on Thursday, June 11th. BTIG Research reiterated a “buy” rating and set a $400.00 price objective on shares of Oracle in a research report on Friday, June 5th. Finally, Piper Sandler increased their price objective on shares of Oracle from $210.00 to $225.00 and gave the company an “overweight” rating in a research note on Thursday, June 11th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty-eight have given a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $263.97.
Oracle Company Profile
Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.
Oracle’s product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.
Featured Stories
- Five stocks we like better than Oracle
- Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
- Insiders Are Betting Big on These 3 Healthcare Stocks
- 3 Stocks for Investors Who Still Believe Cash Is King
- Dollar General and Dollar Tree Are Recovering, But Not for the Same Reason
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.
